Efficacy and safety of interferon α2a as an add-on treatment for refractory Behcet's uveitis

被引：0
|
作者：
Zheng, W. J. [1 ]
Shi, J. [1 ]
Zhao, C. [1 ]
Liu, J. J. [1 ]
Zhou, J. X. [1 ]
Gao, F. [1 ]
Zhang, M. F. [1 ]
机构：
[1] Peking Union Med Coll Hosp, Beijing, Peoples R China
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2018年 / 36卷 / 06期
关键词：
THERAPY; DISEASE;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P059
引用
收藏
页码：S177 / S177
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety evaluation of safinamide as an add-on treatment to levodopa for parkinson's disease
    Kurihara, Kanako
    Mishima, Takayasu
    Fujioka, Shinsuke
    Tsuboi, Yoshio
    [J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (02) : 137 - 147
  • [32] Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Behcet's Uveitis Not Responding to Conventional Therapy
    Yang, Peizeng
    Huang, Guo
    Du, Liping
    Ye, Zi
    Hu, Ke
    Wang, Chaokui
    Qi, Jian
    Liang, Liang
    Wu, Lili
    Cao, Qingfeng
    Kijlstra, Aize
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2019, 27 (01) : 7 - 14
  • [33] Efficacy and safety of systemic infliximab for uveitis in Behcet's disease
    Tobe, Aya
    Oshitari, Toshiyuki
    Yamamoto, Shuichi
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [34] Efficacy of infliximab in refractory posterior uveitis in Behcet's disease patients
    El Garf, Ayman K.
    Shahin, Amira A.
    Shawky, Sherif A.
    Azim, Mohammed A.
    Effat, Dina A.
    Abdelrahman, Sherry K.
    [J]. EGYPTIAN RHEUMATOLOGIST, 2018, 40 (02): : 93 - 97
  • [35] Efficacy of Biosimilar Adalimumab in the Treatment of Behcet's Uveitis
    Soheilian, Masoud
    Ebrahimiadib, Nazanin
    Hedayatfar, Alireza
    Hosseini, Maryam
    Zarei, Mohammad
    Anjidani, Nassim
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2022, 30 (06) : 1495 - 1500
  • [36] Behcet's disease:: uveitis-therapy with interferon α2a -: prospective clinical study in 33 patients
    Stübiger, N
    Kötter, I
    Deuter, C
    Zierhut, M
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2001, 218 (12) : 768 - 773
  • [37] INTERFERON ALFA-2A IN TREATMENT OF REFRACTORY UVEITIS ASSOCIATED BEHCET'S DISEASE: A SINGLE-CENTRE EXPERIENCE iN CHINA
    Zheng, W.
    Shi, J.
    Zhao, C.
    Zhang, M.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (06) : S184 - S184
  • [38] Treatment of ocular symptoms of Behcet's disease with interferon α2a:: a pilot study
    Kötter, I
    Eckstein, AK
    Stübiger, N
    Zierhut, M
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 1998, 82 (05) : 488 - 494
  • [39] Recombinant human interferon-α2a in the treatment of ocular Behcet's disease
    Stubiger, N
    Kotter, I
    Thiel, HJ
    Zierhut, M
    [J]. UVEITIS TODAY, 1998, 1158 : 303 - 306
  • [40] Evaluation of the Long-Term Efficacy and Safety of Infliximab Treatment for Uveitis in Behcet's Disease
    Takeuchi, Masaru
    Kezuka, Takeshi
    Sugita, Sunao
    Keino, Hiroshi
    Namba, Kenichi
    Kaburaki, Toshikatsu
    Maruyama, Kazuichi
    Nakai, Kei
    Hijioka, Kuniaki
    Shibuya, Etsuko
    Komae, Keiko
    Hori, Junko
    Ohguro, Nobuyuki
    Sonoda, Koh-hei
    Mizuki, Nobuhisa
    Okada, Annabelle A.
    Ishibashi, Tatsuro
    Goto, Hiroshi
    Mochizuki, Manabu
    [J]. OPHTHALMOLOGY, 2014, 121 (10) : 1877 - 1884
12345